Search

everythinglearnresearchcommunity

for

Search:↓

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Higher levels of the protein Pannexin-1 may play a role in hair loss in women with PCOS.

A balanced diet and healthy lifestyle help manage PCOS symptoms.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

A postmenopausal woman's high testosterone levels and symptoms improved after removing a tumor from her ovary.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

Losing weight and eating better are key to managing metabolic syndrome and its related conditions.

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.

Belly fat is the main predictor of nonalcoholic fatty liver disease in both women with Polycystic ovary syndrome and healthy women.

Certain gene variants in estrogen receptors are linked to polycystic ovary syndrome, mainly affecting metabolism, in Tunisian women.

Certain genetic variations in OCT1 may improve insulin sensitivity with metformin in women with PCOS.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

Adults should not consume more than 255 micrograms of selenium per day to avoid risk of hair loss and other side effects.

The document concludes that more research is needed to fully understand the causes of PCOS.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Women with PCOS have thicker parafoveal areas in their retinas, but their macular blood vessel density is normal.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

A new mutation in the CYP11B1 gene was found in a woman with mild hyperandrogenemia, a rare cause of non-classic congenital adrenal hyperplasia.

Ring Chromosome 11 may be linked to conditions like early puberty, excessive hair growth, hair loss, and type 2 diabetes.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.